X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs460365-   
Low Rs305264-   
Sales per share (Unadj.) Rs92.1108.7-  
Earnings per share (Unadj.) Rs14.8-27.4-  
Cash flow per share (Unadj.) Rs18.5-22.7-  
Dividends per share (Unadj.) Rs3.200-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs68.085.3-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.22.9 143.5%   
Avg P/E ratio x25.8-11.5 -224.8%  
P/CF ratio (eoy) x20.7-13.9 -149.4%  
Price / Book Value ratio x5.63.7 152.6%  
Dividend payout %21.60-   
Avg Mkt Cap Rs m391,58153,081 737.7%   
No. of employees `00016.94.3 392.6%   
Total wages/salary Rs m15,0023,331 450.3%   
Avg. sales/employee Rs Th5,594.54,273.4 130.9%   
Avg. wages/employee Rs Th890.1776.0 114.7%   
Avg. net profit/employee Rs Th899.9-1,076.8 -83.6%   
INCOME DATA
Net Sales Rs m94,29518,346 514.0%  
Other income Rs m1,286128 1,001.0%   
Total revenues Rs m95,58118,474 517.4%   
Gross profit Rs m19,036-3,179 -598.8%  
Depreciation Rs m3,750792 473.6%   
Interest Rs m450497 90.6%   
Profit before tax Rs m16,122-4,339 -371.5%   
Minority Interest Rs m338-12 -2,794.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,289271 475.4%   
Profit after tax Rs m15,168-4,623 -328.1%  
Gross profit margin %20.2-17.3 -116.5%  
Effective tax rate %8.0-6.2 -128.0%   
Net profit margin %16.1-25.2 -63.8%  
BALANCE SHEET DATA
Current assets Rs m60,22313,437 448.2%   
Current liabilities Rs m53,0587,560 701.8%   
Net working cap to sales %7.632.0 23.7%  
Current ratio x1.11.8 63.9%  
Inventory Days Days70111 63.0%  
Debtors Days Days88124 71.1%  
Net fixed assets Rs m72,9847,832 931.9%   
Share capital Rs m1,02485 1,202.2%   
"Free" reserves Rs m68,5760-   
Net worth Rs m69,60014,399 483.4%   
Long term debt Rs m24,6845,060 487.8%   
Total assets Rs m152,20727,201 559.6%  
Interest coverage x36.8-7.7 -476.3%   
Debt to equity ratio x0.40.4 100.9%  
Sales to assets ratio x0.60.7 91.9%   
Return on assets %10.3-15.2 -67.7%  
Return on equity %21.8-32.1 -67.9%  
Return on capital %17.9-19.8 -90.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,4060-   
CASH FLOW
From Operations Rs m13,4951,566 861.8%  
From Investments Rs m-29,103-481 6,052.8%  
From Financial Activity Rs m23,1584,592 504.3%  
Net Cashflow Rs m7,5565,678 133.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare CADILA HEALTHCARE With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: ELDER PHARMA  ALEMBIC LTD  UNICHEM LAB  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 22, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - IPCA LABS COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS